Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin

British Journal of Nutrition

Volumn 111, Issue 5, 2014, Pages 773-784

  Urwin, Heidi J ^a   Miles, Elizabeth A ^b   Noakes, Paul S ^b   Kremmyda, Lefkothea Stella ^b   Vlachava, Maria ^b   Diaper, Norma D ^b   Godfrey, Keith M ^b,c   Calder, Philip C ^b,c   Vulevic, Jelena ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Gut microbiota; Infants; Long chain PUFA; Oily fish; Pregnancy; Salmon

Indexed keywords

CALGRANULIN; SECRETORY IMMUNOGLOBULIN; BIOLOGICAL MARKER;

ARTICLE; ATOPOBIUM; BACTERIAL COUNT; CONTROLLED STUDY; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES MICROFLORA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFANT; INFANT FEEDING; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SALMON; SINGLE BLIND PROCEDURE; SPECIES COMPOSITION; WEIGHT GAIN; ADULT; ANIMAL; CHEMISTRY; CHILD DEVELOPMENT; CONTROLLED CLINICAL TRIAL; FECES; GROWTH, DEVELOPMENT AND AGING; HYPERSENSITIVITY; IMMUNOLOGY; INFANT NUTRITION; INTESTINE; MATERNAL NUTRITION; MICROBIOLOGY; MUCOSAL IMMUNITY; NEWBORN; RISK; SEA FOOD; UNITED KINGDOM;

ATOPOBIUM; BACTERIA (MICROORGANISMS);

ADULT; ANIMALS; BIOLOGICAL MARKERS; CHILD DEVELOPMENT; FECES; FEMALE; GREAT BRITAIN; HUMANS; HYPERSENSITIVITY; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INTESTINES; LEUKOCYTE L1 ANTIGEN COMPLEX; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK; SALMON; SEAFOOD; SINGLE-BLIND METHOD; WEIGHT GAIN;

EID: 84899760227     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003097     Document Type: Article

References (51)

1. Mackie RI, Sghir A &Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69, 1035S-1045S.
2. Kelly D, King T &Aminov R (2007) Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622, 58-69.
3. Martin R, Nauta AJ, Ben Amor K, et al. (2010) Early life: gut microbiota and immune development in infancy. Benef Microbes 1, 367-382.
4. Biasucci G, Rubini M, Riboni S, et al. (2010) Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 86, Suppl. 1, 13-15.
5. Penders J, Thijs C, Vink C, et al. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521.
6. Fallani M, Young D, Scott J, et al. (2010) Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51, 77-84.
7. Roger LC &McCartney AL (2010) Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 156, 3317-3328.
8. Collado MC, Isolauri E, Laitinen K, et al. (2010) Effect of mothers weight on infants microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr 92, 1023-1030.
9. Penders J, Stobberingh EE, van den Brandt PA, et al. (2007) The role of the intestinal microbiota in the development of atopic disorders. Allergy 62, 1223-1236.
10. Munukka E, Wiklund P, Pekkala S, et al. (2012) Women with and without metabolic disorder differ in their gut microbiota composition. Obesity (Silver Spring) 20, 1082-1087.
11. Manco M, Putignani L &Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31, 817-844.
12. Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736.
13. Sanz Y (2011) Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr 94, 2000S-2005S.
14. Rautava S, Collado MC, Salminen S, et al. (2012) Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 102, 178-184.
15. Grzeskowiak L, Gronlund MM, Beckmann C, et al. (2012) The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18, 7-13.
16. Andersen AD, Molbak L, Thymann T, et al. (2011) Dietary long-chain n-3 PUFA, gut microbiota and fat mass in early postnatal piglet development-exploring a potential interplay. Prostaglandins Leukot Essent Fatty Acids 85, 345-351.
17. Liu T, Hougen H, Vollmer AC, et al. (2012) Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids. Anaerobe 18, 331-337.
18. Bomba A, Nemcova R, Gancarcikova S, et al. (2002) Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr 88, Suppl. 1, S95-S99.
19. Leonard SG, Sweeney T, Bahar B, et al. (2011) Effect of dietary seaweed extracts and fish oil supplementation in sows on performance, intestinal microflora, intestinal morphology, volatile fatty acid concentrations and immune status of weaned pigs. Br J Nutr 105, 549-560.
20. Andersen AD, Molbak L, Michaelsen KF, et al. (2011) Molecular fingerprints of the human fecal microbiota from 9 to 18 months old and the effect of fish oil supplementation. J Pediatr Gastroenterol Nutr 53, 303-309.
21. Nielsen S, Nielsen DS, Lauritzen L, et al. (2007) Impact of diet on the intestinal microbiota in 10-month-old infants. J Pediatr Gastroenterol Nutr 44, 613-618.
22. Fava F, Gitau R, Griffin BA, et al. (2012) The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome at-risk population. Int J Obes (Lond) 37, 216-223.
23. Miles EA, Noakes PS, Kremmyda LS, et al. (2011) The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. Am J Clin Nutr 94, 1986S-1992S.
24. Urwin HJ, Miles EA, Noakes PS, et al. (2012) Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. J Nutr 142, 1603-1610.
25. Crozier SR, Robinson SM, Borland SE, et al. (2006) Dietary patterns in the Southampton Womens Survey. Eur J Clin Nutr 60, 1391-1399.
26. Vlachava M (2010) Salmon in Pregnancy Study (SIPS): the effects of increased oily fish intake during pregnancy on maternal and cord blood fatty acid composition, cord blood immunity and atopy outcomes in infants at 6 months of age. Doctoral Thesis, University of Southampton, School of Medicine.
27. Daims H, Stoecker K &Wagner M (2005) Fluorescence in situ hybridization for the detection of prokaryotes. In Molecular Microbial Ecology, pp. 213-239 [AM Osborn and CJ Smith, editors]. New York, NY: Taylor &Francis.
28. Loy A, Maixner F, Wagner M, et al. (2007) probeBase - an online resource for rRNA-targeted oligonucleotide probes: new features 2007. Nucleic Acids Res 35, D800-D804.
29. Blaut M, Collins MD, Welling GW, et al. (2002) Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 87, Suppl. 2, S203-S211.
30. IOM (2009) Weight Gain During Pregnancy, Reexamining the Guidelines. Committee to Reexamine IOM Pregnancy Weight Guidelines. Washington, DC: National Academies Press.
31. Collado MC, Calabuig M &Sanz Y (2007) Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol 8, 9-14.
32. Proctor LM (2011) The Human Microbiome Project in 2011 and beyond. Cell Host Microbe 10, 287-291.
33. Noakes PS, Vlachava M, Kremmyda LS, et al. (2012) Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. Am J Clin Nutr 95, 395-404.
34. Willemsen LE, Koetsier MA, Balvers M, et al. (2008) Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro. Eur J Nutr 47, 183-191.
35. Kankaanpaa PE, Salminen SJ, Isolauri E, et al. (2001) The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett 194, 149-153.
36. Satokari R, Gronroos T, Laitinen K, et al. (2009) Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 48, 8-12.
37. Jimenez E, Marin ML, Martin R, et al. (2008) Is meconium from healthy newborns actually sterile? Res Microbiol 159, 187-193.
38. Fanaro S, Boehm G, Garssen J, et al. (2005) Galactooligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr Suppl 94, 22-26.
39. Brandtzaeg P, Nilssen DE, Rognum TO, et al. (1991) Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am 20, 397-439.
40. Hanson LA (2007) Session 1: feeding and infant development breast-feeding and immune function. Proc Nutr Soc 66, 384-396.
41. Chaturvedi P, Warren CD, Buescher CR, et al. (2001) Survival of human milk oligosaccharides in the intestine of infants. Adv Exp Med Biol 501, 315-323.
42. Newburg DS, Ruiz-Palacios GM &Morrow AL (2005) Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25, 37-58.
43. Scholtens PA, Alliet P, Raes M, et al. (2008) Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr 138, 1141-1147.
44. Bakker-Zierikzee AM, Tol EA, Kroes H, et al. (2006) Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 17, 134-140.
45. Costa F, Mumolo MG, Bellini M, et al. (2003) Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 35, 642-647.
46. Olafsdottir E, Aksnes L, Fluge G, et al. (2002) Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 91, 45-50.
47. Rosti L, Braga M, Fulcieri C, et al. (2011) Formula milk feeding does not increase the release of the inflammatorymarker calprotectin, compared to human milk. Pediatr Med Chir 33, 178-181.
48. Savino F, Castagno E, Calabrese R, et al. (2010) High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 97, 299-304.
49. Arslan G, Brunborg LA, Froyland L, et al. (2002) Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 37, 935-940.
50. Santacruz A, Collado MC, Garcia-Valdes L, et al. (2010) Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 104, 83-92.
51. Collado MC, Isolauri E, Laitinen K, et al. (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88, 894-899.